Febrile neutropenia, n (%)
|
11 (73.3)
|
11 (73.3)
|
1
|
Oral mucositis, n (%)
|
14 (93.3)
|
15 (100)
|
1
|
Oral mucositis severity grade 3–4, n (%)
|
6 (40)
|
9 (60)
|
0.27
|
Diarrhea, n (%)
|
14 (93.3)
|
14 (93.3)
|
1
|
Hemorrhagic cystitis, n (%)
|
5 (33.3)
|
5 (33.3)
|
1
|
Graft-versus-host disease, n (%)
|
6 (40)
|
7 (46.7)
|
1
|
Bacterial infection, n (%)
|
1 (6.7)
|
2 (13.3)
|
1
|
Viral infection, n (%)
|
10 (66.7)
|
6 (40)
|
0.14
|
Day of neutrophil engraftment, mean days ± SD
|
14 ± 2.8
|
14.2 ± 3.9
|
0.87
|
Duration of febrile neutropeniaa, days
|
5 (2–10)
|
6.5 (1–21)
|
0.8
|
Duration of mucositis, mean days ± SD
|
9 ± 3.8
|
9 ± 4.7
|
0.96
|
Duration of diarrheaa, days
|
11.5 (2–44)
|
15.5 (2–37)
|
0.42
|
Duration of need of TPN, days ± SD
|
13 ± 7.1
|
11 ± 6.6
|
0.42
|
Duration of hospitalization after day 0a, days
|
29 (18–83)
|
24 (15–54)
|
0.13
|
Mortality, n (%)
|
0
|
2 (13.3)
|
0.48
|